Clinical Trial Update: Optimal Dosage of Acetazolamide for OSA Treatment [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the optimal dosage of acetazolamide for obstructive sleep apnea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• ACETAZOLAMIDE (acetazolamide)

Snippet

Sponsor: University Hospital, Antwerp | Conditions: Obstructive Sleep Apnea | Phase 4 | Status: COMPLETED